Giovan B. Ruffo

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Narratives unveil knowledge and awareness-related issue, reinforcing patients' self-identity in sickle cell disease.

Narratives unveil knowledge and awareness-related issue, reinforcing patients' self-identity in sickle cell disease.

Journal: Orphanet journal of rare diseases

Published: August 19, 2025

Quantifying Morbidity Risk Attributed to Red-Cell Transfusion Volume in Optimally Transfused Patients With β-Thalassemia.

Quantifying Morbidity Risk Attributed to Red-Cell Transfusion Volume in Optimally Transfused Patients With β-Thalassemia.

Journal: American journal of hematology

Published: August 15, 2025

Lifetime Risk of Liver Disease in Patients With β-Thalassemia: Data From the de-LIGHT Retrospective Cohort Study.

Lifetime Risk of Liver Disease in Patients With β-Thalassemia: Data From the de-LIGHT Retrospective Cohort Study.

Journal: European journal of haematology

Published: April 26, 2025

Pregnancy and childbirth in women with thalassemia: past and present.

Pregnancy and childbirth in women with thalassemia: past and present.

Journal: Haematologica

Published: April 04, 2025

Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.

Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.

Journal: American journal of hematology

Published: March 14, 2025

Impact of lifetime anaemia and iron control on outcomes in β-thalassaemia: Data from the longitudinal de-LIGHT study.

Impact of lifetime anaemia and iron control on outcomes in β-thalassaemia: Data from the longitudinal de-LIGHT study.

Journal: British journal of haematology

Published: March 13, 2025

COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.

COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.

Journal: Orphanet journal of rare diseases

Published: January 04, 2025

Nephrological Complications in Hemoglobinopathies: SITE Good Practice.

Nephrological Complications in Hemoglobinopathies: SITE Good Practice.

Journal: Journal of clinical medicine

Published: August 16, 2023

Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.

Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.

Journal: American journal of hematology

Published: October 29, 2021

Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds.

Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds.

Journal: Annals of hematology

Published: January 21, 2021

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study.

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study.

Journal: Experimental hematology & oncology

Published: May 30, 2020

Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.

Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.

Journal: British journal of haematology

Published: July 26, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026